In It Together: Encouraging Greater Participation in Alzheimer’s Clinical Trials
Published on:
Diane Bovenkamp, PhD, Vice President for Scientific Affairs at BrightFocus Foundation discusses why the prevention or treatment of Alzheimer's disease can only happen with the generosity and commitment of volunteers enrolling in clinical trials in an article published on the Antidote website.
Antidote is a digital health company with the mission to accelerate breakthroughs in potentially life-saving treatments by bridging the gap between medical research and the people who need it.